Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Solid Tumors
Sort By
Newest First
1 / 1
1 / 1
Announcement
Inceptor Bio and GRIT Bio Cooperate to Advance IB-T101, a Next-Generation Solid Tumor CAR-T Utilizing the OUTLAST™ Platform
Inceptor Bio
PR-12-24-NI-142
Dec 18, 2024
Cell Therapy
Engineering Immune Cells to Realize the Promise of Cancer Cell Therapies
Beau Webber, Ph.D.
Luminary Therapeutics
PAO-08-23-CL-04
Sep 05, 2023
Therapeutic Candidate
CytoDyn Takes Steps towards a Brighter Future
Cyrus Arman, Ph.D.
CytoDyn
PAO-02-23-CL-04
Feb 06, 2023
CAR-T and iPSC Platform Technologies
Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR-T and Engineered iPSC Platform Technologies at the SITC 37th Annual Meeting
Umoja Biopharma
PR-M11-22-06
Nov 11, 2022
Cell Therapy
Fighting Solid Tumors by Targeting Neoantigens in a Personalized Manner
Mark Shlomchik, M.D., Ph.D.
BlueSphere Bio
PAO-06-022-CL-03
Jun 06, 2022
Oncology Collaboration
Tegmine Therapeutics Announces Collaboration with Alloy Therapeutics to Advance Solid Tumor Treatment
Tegmine Therapeutics
PR-M04-22-03
Apr 06, 2022
Phase I Trial
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center
Anixa Biosciences
PR-M03-22-17
Mar 30, 2022
Strategic Collaboration
Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors
Bayer
PR-M11-20-030
Dec 10, 2020
Clinical Study
BioLineRx Initiates Phase 1/2a Clinical Study for AGI-134, a Novel Immunotherapy for Treatment of Solid Tumors
BioLineRx
PR-M08-18-NI-030
Aug 08, 2018
